ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $39,000 | -99.7% | 839 | -99.9% | 0.00% | -100.0% |
| Q1 2019 | $13,726,000 | +91406.7% | 563,031 | +54037.6% | 0.03% | – |
| Q4 2018 | $15,000 | -97.6% | 1,040 | -97.5% | 0.00% | -100.0% |
| Q3 2018 | $627,000 | -39.1% | 41,221 | -32.8% | 0.00% | -66.7% |
| Q2 2018 | $1,030,000 | +3.2% | 61,343 | +0.3% | 0.00% | 0.0% |
| Q1 2018 | $998,000 | +7028.6% | 61,165 | +5445.3% | 0.00% | – |
| Q4 2017 | $14,000 | 0.0% | 1,103 | -2.6% | 0.00% | – |
| Q3 2017 | $14,000 | +40.0% | 1,132 | -6.0% | 0.00% | – |
| Q2 2017 | $10,000 | -23.1% | 1,204 | -21.2% | 0.00% | – |
| Q1 2017 | $13,000 | -13.3% | 1,528 | -8.9% | 0.00% | – |
| Q4 2016 | $15,000 | +650.0% | 1,678 | +363.5% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 362 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -98.2% | 362 | -98.1% | 0.00% | – |
| Q1 2016 | $56,000 | -30.9% | 19,140 | 0.0% | 0.00% | – |
| Q4 2015 | $81,000 | -6.9% | 19,140 | 0.0% | 0.00% | – |
| Q3 2015 | $87,000 | -37.0% | 19,140 | 0.0% | 0.00% | – |
| Q2 2015 | $138,000 | – | 19,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |